BindingDB logo
myBDB logout

BDBM106963 US8592581, 14

SMILES: C[C@@H](O)CNc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1

InChI Key: InChIKey=JXKQPAFSJBFUHW-GFCCVEGCSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 106963   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cyclin-dependent kinase 9


(Homo sapiens (Human))
BDBM106963
PNG
(US8592581, 14)
Show SMILES C[C@@H](O)CNc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1 |r|
Show InChI InChI=1S/C17H23N7O/c1-11(2)24-10-21-14-15(19-9-13-5-4-6-18-8-13)22-17(23-16(14)24)20-7-12(3)25/h4-6,8,10-12,25H,7,9H2,1-3H3,(H2,19,20,22,23)/t12-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 6.53E+3n/an/an/an/a7.530



Cyclacel Limited; Cancer Research Technology Limited

US Patent


Assay Description
To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u...


US Patent US8592581 (2013)


BindingDB Entry DOI: 10.7270/Q25X27J9
More data for this
Ligand-Target Pair
Cyclin-dependent kinase 2


(Homo sapiens (Human))
BDBM106963
PNG
(US8592581, 14)
Show SMILES C[C@@H](O)CNc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1 |r|
Show InChI InChI=1S/C17H23N7O/c1-11(2)24-10-21-14-15(19-9-13-5-4-6-18-8-13)22-17(23-16(14)24)20-7-12(3)25/h4-6,8,10-12,25H,7,9H2,1-3H3,(H2,19,20,22,23)/t12-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 290n/an/an/an/a7.530



Cyclacel Limited; Cancer Research Technology Limited

US Patent


Assay Description
To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates u...


US Patent US8592581 (2013)


BindingDB Entry DOI: 10.7270/Q25X27J9
More data for this
Ligand-Target Pair